September 2013 - Volume 41 - Issue 9
pp: 2069-2251,e191-e245

A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis...

Vincent, Jean-Louis; Ramesh, Mayakonda K.; Ernest, David; More

Critical Care Medicine. 41(9):2069-2079, September 2013.


Feasibility and Cardiac Safety of Inhaled Xenon in Combination With Therapeutic Hypothermia Following Out-of-Hospital Cardiac Arrest*

Arola, Olli J.; Laitio, Ruut M.; Roine, Risto O.; More

Critical Care Medicine. 41(9):2116-2124, September 2013.

Microvascular Effects of Heart Rate Control With Esmolol in Patients With Septic Shock: A Pilot Study*

Morelli, Andrea; Donati, Abele; Ertmer, Christian; More

Critical Care Medicine. 41(9):2162-2168, September 2013.






Extracorporeal Versus Conventional Cardiopulmonary Resuscitation After Ventricular Fibrillation Cardiac Arrest in Rats: A Feasibility Trial*

Janata, Andreas; Drabek, Tomas; Magnet, Ingrid A. M.; More

Critical Care Medicine. 41(9):e211-e222, September 2013.



1 2 3 4 5